By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs said after the close of the market Tuesday that it has inked two new distribution agreements with Bioke and Imperial Life Sciences.

Bioke, a Dutch firm that sells reagents for signal transduction, cell culture, and molecular biology applications, serves markets in the Netherlands, Belgium, and Luxembourg. ILS supplies reagents for genomics, proteomics, cell biology, and imaging applications in India.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.